期刊文献+

利尿剂对老年慢性心力衰竭伴心房颤动患者的疗效观察

下载PDF
导出
摘要 探讨利尿剂治疗老年慢性心力衰竭(Chronic heart failure,CHF)并发阵发性心房颤动的疗效及安全性。小剂量利尿剂能显著提高CHF伴心房颤动患者的窦性心律转复率,阻止或延缓心肌损害,且具有较高的安全性。
作者 阮景贤
出处 《健康研究》 CAS 2014年第4期439-440,共2页 Health Research
  • 相关文献

参考文献6

  • 1代容.胺碘酮治疗老年充血性心力衰竭合并心房颤动的临床观察[J].中国药房,2011,22(40):3784-3786. 被引量:6
  • 2李霞,陈欣,薛金红.心房颤动合并慢性心力衰竭患者血浆利钠肽水平变化的研究[J].天津医药,2011,39(5):465-466. 被引量:7
  • 3Helme Silvet,Lee Ann Hawkins,Alan K. Jacobson.Heart Rate Control in Patients With Chronic Atrial Fibrillation and Heart Failure[J].Congestive Heart Failure.2012(1)
  • 4John W. Eikelboom,Stuart J. Connolly,Peggy Gao,Ernesto Paolasso,Raffaele De Caterina,Steen Husted,Martin O’Donnell,Salim Yusuf,Robert G. Hart.Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease[J].Journal of Stroke and Cerebrovascular Diseases.2012(6)
  • 5Nancy Frasure-Smith,Fran?ois Lespérance,Martine Habra,Mario Talajic,Paul Khairy,Paul Dorian,Denis Roy.Elevated Depression Symptoms Predict Long-Term Cardiovascular Mortality in Patients With Atrial Fibrillation and Heart Failure[J].Circulation.2009(2)
  • 6Anique Ducharme,Karl Swedberg,Marc A. Pfeffer,Alain Cohen-Solal,Christopher B. Granger,Aldo P. Maggioni,Eric L. Michelson,John J.V. McMurray,Lars Olsson,Jean L. Rouleau,James B. Young,Bertil Olofsson,Margareta Puu,Salim Yusuf.Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program[J].American Heart Journal.2006(1)

二级参考文献13

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 2廖继全.胺碘酮治疗心衰并心房纤颤的疗效观察[J].右江医学,2004,32(5):444-445. 被引量:1
  • 3Raymond I,Groenning BA,Hildebrandt PR,et al.The influence of age,sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population[J].Heart,2003,89(7):745-751.
  • 4Wozakowska-Kaplon B,Opolski G,Herman Z,et al.Natriuretic peptides in patients with atrial fibrillation[J].Cardiol J.2008,15(6):525-529.
  • 5Rossi A,Enriquez-Sarano M,Burnett JC,et al.Natriuretic peptide levels in atrial fibrillation:a prospective hormonal and Doppler-echoeardiographic study[J].J Am Coll Cardiol,2000,35(5):1256-1262.
  • 6Jug B,Sebesljen M,Sabovic M,et al.Atrial fibrillation is an independent determinant of increased NT-proBNP levels in outpatients with signs and symptoms of heart failure[J].Wien Klin Wochenschr,2009,121(21-22):700-706.
  • 7Luchner A,Stevens TL,Borgeson DD,et al.Differential atrial and ventricular expression of Myocardial BNP during evolution of heart failure[J].Am J Physiol,1998,274(5 Pt 2):H1684-1689.
  • 8Silvet H,Young-Xu Y,Walleigh D,et al.Brain natriuretic peptide is elevated in outpatients with atrial fibrillation[J].Am J Cardiol,2003,92(9):l 124-1127.
  • 9I noue S,Murakami Y,Sano K,et al.Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation[J].J Card Fail,2000,6(2):92-96.
  • 10Tuinenburg A,Brundel B,Van Gelder I,et al.Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation[J].J Cardiovasc Electrophysiol,1999,10(6):827-835.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部